Lenvatinib in elderly hepatocellular carcinoma patients, a new therapeutic option in first line.

ABSTRACT:

SUBMITTER: Roth GS 

PROVIDER: S-EPMC7723611 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature